Cargando…
Implications of GABAergic Neurotransmission in Alzheimer’s Disease
Alzheimer’s disease (AD) is characterized pathologically by the deposition of β-amyloid peptides (Aβ) and the accumulation of neurofibrillary tangles (NFTs) composed of hyper-phosphorylated tau. Regardless of the pathological hallmarks, synaptic dysfunction is widely accepted as a causal event in AD...
Autores principales: | Li, Yanfang, Sun, Hao, Chen, Zhicai, Xu, Huaxi, Bu, Guojun, Zheng, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763334/ https://www.ncbi.nlm.nih.gov/pubmed/26941642 http://dx.doi.org/10.3389/fnagi.2016.00031 |
Ejemplares similares
-
GABAergic neurotransmission and new strategies of neuromodulation to compensate synaptic dysfunction in early stages of Alzheimer’s disease
por: Nava-Mesa, Mauricio O., et al.
Publicado: (2014) -
Compensatory Mechanisms Modulate the Neuronal Excitability in a Kainic Acid-Induced Epilepsy Mouse Model
por: Pan, Gaojie, et al.
Publicado: (2018) -
Influence of glutamatergic and GABAergic neurotransmission on obstructive sleep apnea
por: Kaczmarski, Piotr, et al.
Publicado: (2023) -
Extrasynaptic and Postsynaptic Receptors in Glycinergic and GABAergic Neurotransmission: A Division of Labor?
por: Muller, Emilie, et al.
Publicado: (2008) -
GABAergic Inhibitory Interneuron Deficits in Alzheimer’s Disease: Implications for Treatment
por: Xu, Yilan, et al.
Publicado: (2020)